ARMISTICE CAPITAL, LLC
CIK 1601086 · last filed 2023-06-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$233.31M
Companies
15
Total Filings
83
Lifetime Open-Market Net
$140.94M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTX | Director | 3,191 | $19.52 | $62.3K | -$1.94M | 6 | 2023-06-28 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Director | 39,662,442 | $2.93 | $116.21M | $51.07M | 15 | 2021-08-06 |
| Vyome Holdings, Inc (RSLS) Delisted | 10%+ Owner | 48 | $15.68 | $753 | $0 | 1 | 2021-06-29 |
| EYEG | Director | 6,693,202 | $34.73 | $232.42M | $36.97M | 10 | 2021-01-08 |
| AYTU | Director | 133,334 | $2.13 | $284.0K | $24.00M | 1 | 2020-12-15 |
| TENX | Director | 2,519 | $15.80 | $39.8K | $277.6K | 2 | 2020-09-09 |
| Vaxart, Inc. (VXRT) Delisted | Director | 16,800,000 | $0.32 | $5.38M | -$1.57M | 1 | 2020-05-29 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | 10%+ Owner | 4,468,000 | — | — | $1.25M | 2 | 2020-03-18 |
| Traws Pharma, Inc. (ONTXW) Delisted | 10%+ Owner | 1,633,404 | $0.07 | $109.6K | -$39.0K | 1 | 2019-09-25 |
| ACHV | 10%+ Owner | 81,909 | $6.18 | $506.2K | -$404.5K | 1 | 2019-06-13 |
| Del Frisco's Restaurant Group, Inc. (DFRG) Delisted | 10%+ Owner | 6,525,000 | — | — | $29.99M | 11 | 2019-06-06 |
| Valeritas Holdings Inc. (VLRX) Delisted | 10%+ Owner | 2,116,000 | — | — | $465.8K | 4 | 2019-05-28 |
| CASSAVA SCIENCES INC (PTIE) Delisted | 10%+ Owner | 1,651,340 | — | — | -$2.02M | 1 | 2018-10-05 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | 10%+ Owner | 862,146 | — | — | $69.2K | 1 | 2018-06-22 |
| Avalo Therapeutics, Inc. (CERCW) Delisted | Director | 32,440,000 | — | — | $2.82M | 8 | 2018-04-23 |
Recent Filings · Page 4 of 9
83 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-27 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Buy (P) | +108,000 | $895.3K | EDGAR |
| 2020-02-10 | EYEG | Buy (P) | +69,000 | $421.4K | EDGAR |
| 2020-02-05 | Avalo Therapeutics, Inc. (CERC) Delisted | Buy (P) | +3,768,846 | $15.00M | EDGAR |
| 2020-01-31 | — | Buy (P) | +9,000 | $64.2K | |
| 2019-12-11 | — | Buy (P) | +7,569 | $39.4K | |
| 2019-11-27 | — | Buy (P) | +6,000 | $32.6K | |
| 2019-11-22 | — | Buy (P) | +8,385 | $44.6K | |
| 2019-11-18 | — | Buy (P) | +11,205 | $75.9K | |
| 2019-09-25 | — | Mixed | +20,100,000 | $402.0K | |
| 2019-09-25 | Traws Pharma, Inc. (ONTXW) Delisted | Sell (S) | −30,747 | -$39.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.